Immature platelets and cardiovascular events in patients with stable coronary artery disease.

What is the context? Many patients with coronary artery disease (CAD) have reduced antiplatelet effect of aspirinThe reduced antiplatelet effect of aspirin is most likely multifactorial and may partly be explained by immature plateletsWhat is new? In a cohort of 900 stable CAD patients, we measured markers of immature platelets and studied their relation to cardiovascular events during a 3-year follow-upOur study demonstrated that markers of immature platelets did not predict cardiovascular events in our cohortWhat is the impact? The findings from the present study suggest that immature platelets, measured in a stable phase, do not have a major role in predicting future cardiovascular events in CAD patients.